156 related articles for article (PubMed ID: 38132253)
1. The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine.
Nel I; Münch C; Shamkeeva S; Heinemann ML; Isermann B; Aktas B
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132253
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
[TBL] [Abstract][Full Text] [Related]
4. Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy.
Filipits M; Kainz V; Sebek V; Zach H; On Behalf Of The Liquid Biopsy Collaborative Study Group
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444638
[TBL] [Abstract][Full Text] [Related]
5. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
6. Detection and quantification of
Silveira C; Sousa AC; Janeiro A; Malveiro S; Teixeira E; Brysch E; Pantarotto M; Felizardo M; Madureira R; Nogueira F; Guimarães C; Matos C; Canário D; Bruges-Armas J; Carmo-Fonseca M
Transl Lung Cancer Res; 2021 Mar; 10(3):1200-1208. PubMed ID: 33889502
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
8. A novel urine cell-free DNA preservation solution and its application in kidney transplantation.
Zhou Q; Liu F; Guo L; Chen R; Yuan X; Li C; Shu L; Liu H; Zhou Y; Wu Y; Shi H; Zhao H; Jiang T
Nephrology (Carlton); 2021 Aug; 26(8):684-691. PubMed ID: 33866646
[TBL] [Abstract][Full Text] [Related]
9. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
[TBL] [Abstract][Full Text] [Related]
10. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
11. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.
Shen N; Zhu B; Zhang W; Nian B; Xu X; Yu L; Ruan X; Chen S; Liu Y; Cao X; Shi X; Li Z; Huang X; Wang X; Chen C; Xiong L; Zhang D; Fu X; Zhang Y
Front Oncol; 2022; 12():891917. PubMed ID: 35600407
[TBL] [Abstract][Full Text] [Related]
13. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
[TBL] [Abstract][Full Text] [Related]
14. Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with
Nishio K; Sakai K; Nishio M; Seto T; Visseren-Grul C; Carlsen M; Matsui T; Enatsu S; Nakagawa K
Transl Lung Cancer Res; 2023 Aug; 12(8):1702-1716. PubMed ID: 37691865
[TBL] [Abstract][Full Text] [Related]
15. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
Terp SK; Pedersen IS; Stoico MP
J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.
Keup C; Storbeck M; Hauch S; Hahn P; Sprenger-Haussels M; Tewes M; Mach P; Hoffmann O; Kimmig R; Kasimir-Bauer S
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781720
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of QS3D versus droplet digital PCR for quantitative measures of EGFR T790M mutation from identical plasma.
Guo Q; Wang L; Liang X; Zhao M; Huang X; Xu W; Lou J; Qiao L
Heliyon; 2022 Nov; 8(11):e11339. PubMed ID: 36387507
[TBL] [Abstract][Full Text] [Related]
18. A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis.
Yuan H; Zhu ZZ; Lu Y; Liu F; Zhang W; Huang G; Zhu G; Jiang B
Yonsei Med J; 2012 Jan; 53(1):132-7. PubMed ID: 22187243
[TBL] [Abstract][Full Text] [Related]
19. Five Technologies for Detecting the
Chen YL; Lin CC; Yang SC; Chen WL; Chen JR; Hou YH; Lu CC; Chow NH; Su WC; Ho CL
Front Oncol; 2019; 9():631. PubMed ID: 31380273
[TBL] [Abstract][Full Text] [Related]
20. [Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis].
Su F; Zheng K; Fu Y; Wu Q; Tang Y; Wang W; Jiang L
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):389-396. PubMed ID: 29764589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
